Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
MacroGenics
University of Chicago
Eastern Cooperative Oncology Group
Spanish Breast Cancer Research Group
Genmab
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Arcus Biosciences, Inc.
Merck Sharp & Dohme LLC
National Medical Research Radiological Centre of the Ministry of Health of Russia
R-Pharm
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Genmab
H. Lee Moffitt Cancer Center and Research Institute
Fondazione Ricerca Traslazionale
Shanghai Miracogen Inc.
Daiichi Sankyo
M.D. Anderson Cancer Center
Washington University School of Medicine
R-Pharm
Janssen Research & Development, LLC
Emory University
Amgen
Montefiore Medical Center
Wake Forest University Health Sciences
Dana-Farber Cancer Institute
Yale University
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
iOnctura
ImmunityBio, Inc.
Gilead Sciences
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Big Ten Cancer Research Consortium
National Cancer Institute (NCI)
Genentech, Inc.
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
BioRay Pharmaceutical Co., Ltd.